Entering text into the input field will update the search result below

AIkido Pharma gets US patent for pancreatic cancer drug DHA-dFdC

Mar. 03, 2022 11:09 AM ETDominari Holdings Inc. (DOMH)By: Ravikash, SA News Editor

Business woman signs a patent. Intellectual property protection concept. Patent attorney.

Irina Vodneva/iStock via Getty Images

  • AIkido Pharma (AIKI +1.4%) announced the issuance of an additional U.S. patent covering its pancreatic cancer drug DHA-dFdC, licensed from the University of Texas at Austin.
  • The company said the U.S. Patent Office issued a U.S. Patent No. 11,219,633, which is expected to

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.